CLChunsheng Li

Chunsheng Li

*This is an algorithmically generated author record based on publicly available information.

Chunsheng Li has a total of 3 co-authors. Here are the top co-authors by number of shared publications:

  • Bo Zhang

    The Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, China

    1 shared publication
  • Ran Xia

    The Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, China

    1 shared publication
  • Xinxin Wang

    The Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, China

    1 shared publication

Latest Publications

  • Open Access

    Gut microbiota in coronary artery disease: a friend or foe?

    by Bo Zhang, Xinxin Wang, Ran Xia, Chunsheng Li

    There is growing interest in the role of gut microbiota in the pathophysiology of several diseases, including coronary artery diseases (CAD). Gut microorganisms may produce beneficial effects in myocardial ischemia either directly in the form of exogenous administration or indirectly by acting on fiber-rich food to produce important cardioprotective components. The harmful effects of gut microbiota in CAD are due to alteration in their composition with a significant decrease in Bacteroidetes and an increase in Firmicutes, Escherichia, Shigella, and Enterococcus. The altered microbiota may produce potentially toxic metabolites, including trimethylamine-N-oxide (TMAO). Indeed, the fasting plasma levels of TMAO are directly correlated to increased risk of major cardiovascular events in CAD patients, and it is proposed as a potential biomarker to predict the onset of major cardiovascular events. It is concluded that the change in the composition of gut microbiota in CAD patients may predispose to more harmful effects. However, exogenous delivery of probiotics may overcome the detrimental effects of myocardial ischemia.